Orion Biotech Opportunities Corp. (ORIA)
| Market Cap | 250.00M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 25.00M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2 |
| Open | - |
| Previous Close | 10.00 |
| Day's Range | 9.68 - 10.00 |
| 52-Week Range | 9.45 - 10.78 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings Date | n/a |
About ORIA
Orion Biotech Opportunities is a newly incorporated blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. We intend to focus on the biotechnology and life sciences industries. In particular, we will target North American, European, and Asian healthcare companies with the potential to drive transformational change through the development and commercialization of nove...
News
Orion Biotech Opportunities Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commenci...
NEW YORK, July 1, 2021 /PRNewswire/ -- Orion Biotech Opportunities Corp. (Nasdaq: ORIAU) (the "Company" or "us") announced that, commencing July 2, 2021, holders of the units sold in the Company's init...
Orion Biotech Opportunities Corp. Announces Pricing of $200,000,000 Initial Public Offering
NEW YORK, May 12, 2021 /PRNewswire/ -- Orion Biotech Opportunities Corp. (the "Company") today announced the pricing of its initial public offering ("IPO") of 20,000,000 units at a price of $10.00 per u...
MSD Partners and Panacea's SPAC Orion Biotech Opportunities files for a $200 million IPO
Orion Biotech Opportunities, a blank check company formed by MSD Partners and Panacea Venture targeting the biotech and life science sectors, filed on Thursday with the SEC to raise up to $200 million i...
Orion Biotech Opportunities IPO Registration Document (S-1)
Orion Biotech Opportunities Corp. has filed to go public with an IPO on the NASDAQ.